MyTherapy App and Charité Kick off Research Project on Post-Transplant Adherence

smartpatientCharité University of Berlin and the MyTherapy App step up their game collaborating on a new research project. A previous pilot study with Prof Elisabeth Steinhagen-Thiessen showed that MyTherapy has a positive impact on medication adherence among elderly patients. In a new research project starting 01 August 2016, kidney transplant patients will use MyTherapy as part of their post-transplant care routines. Under the leadership of Prof. Dr Klemens Budde, 100 patients will use the MyTherapy App over six months. The app (iOS und Android) will act as a support tool for the patients for adhering to their medication regimes, home measurements (e.g. blood pressure) as well as other treatment-related activities. The Charité researchers will evaluate the app’s effectiveness in comparison to a control group of the same size.

It is important especially for transplant patients to fully adhere to their prescribed medications, as the danger of complications after a transplant can otherwise increase. According to Prof Budde “every 1 in 6 kidneys is rejected due to poor adherence”. Prof Budde continues that “based on the positive study results from MyTherapy, we believe this app will help improve post-transplant outcomes”. The results of the study will be presented at an upcoming Nephrology Conference.

About MyTherapy
Keep track of your medications and stay on top of your health. The award-winning MyTherapy app reminds you of the medications you need to take and to get active by tracking your vitals and symptoms. MyTherapy’s built-in health journal summarises your medication and health information so you can oversee your health progress. You can share them with your healthcare provider, helping them better understand your needs or let your family be your safety net, in case you do forget a dose. MyTherapy keeps you in charge of your personal data at all times with strict privacy policies prohibiting the distribution to third parties. MyTherapy’s proven impact on medication adherence and its outstanding ease of usability for patients of all age groups has been demonstrated by several studies with reputable research institutes including Germany’s largest university hospital Charité Berlin. MyTherapy is available free of charge from the iTunes App Store and on Google Play.

For more information please visit: www.mytherapyapp.com

About smartpatient
smartpatient helps patients to take their medication and to implement a healthy lifestyle. Patients of a wide range of conditions and all ages trust smartpatient’s award-winning MyTherapy platform for managing their medication. Clinically evaluated and strictly protecting users’ privacy, MyTherapy stands out as the European answer to digitally supporting the chronically ill. Partners from academia and the healthcare industry rely on smartpatient for improving health outcomes. MyTherapy is available for free on the iTunes App Store and Google Play.

Sebastian Gaede, Philipp Legge and Julian Weddige founded smartpatient in late 2012. The Munich-based company received numerous awards for the MyTherapy platform and the underlying research. Lately smartpatient won the "Smart Service World" technology contest of the German Federal Ministry for Economic Affairs and Energy.

Most Popular Now

SPARK TSL Acquires Sentean Group

SPARK TSL is acquiring Sentean Group, a Dutch company with a complementary background in hospital entertainment and communication, and bringing its Fusion Bedside platform for clinical and patient apps to...

GPT-4 Matches Radiologists in Detecting …

Large language model GPT-4 matched the performance of radiologists in detecting errors in radiology reports, according to research published in Radiology, a journal of the Radiological Society of North America...

ChatGPT Extracts Data for Ischaemic Stro…

In an ischaemic stroke, an artery in the brain is blocked by blood clots and the brain cells can no longer be supplied with blood as a result. Doctors must...

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...